Skip to main content

Table 1 Cytokine polymorphisms and levels in serum or CSF

From: The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ

Cytokinesa

Levelsb

Polymorphisms/haplotypes

Corresponding cytokine expressionc

Resultsd

Methods

Ref.

MCI

AD

Plasma/serum

CSF

Plasma/serum

CSF

IL-1 family [144]

IL-1α

=

\

= or ↓

\

-889 C/T (rs1800587)

T: ↑

* ↑ in EOAD

Meta-analysis

[145]

No * in LOAD.

* ↑ in Caucasians

Meta-analysis

[14]

No * in Asians.

IL-1β

=

↑or =

= or ↑

-511 C/T (rs16944)

?

no*

Meta-analysis

[15]

-31 T/C (rs1143627)

C: ?

*↓ in Italians

Case–control

[25]

−511C/−31 T/IL1RN2

?

*↓ in elderly group of Brazilians

Case–control

[23]

−511C/−31C/IL1RN1

?

* ↑ in Brazilians

Case–control

+3953 C/T (rs1143634)

T: ↑

* ↑ in non-Asians

Meta-analysis

[15], [14]

Exon 5 E1/E2

\

No* in Taiwan population

Case–control

[146]

IL-1ra

\

\

-

↓ [139]

Intron 2 I/II/IV

\

IL-18 [71]

=

\

= or ↑

-607 A/C (rs1946518)

C: ↑

* ↑ in LOAD of Han Chinese.

Case–control

[20]

*↑↑ in ApoE ε4 carrier.

-137 C/G (rs187238)

G: ↑

-607 C or -137 G

* ↑ in LOAD of Han Chinese.

IL-33 [147]

\

\

\

\

rs11792633 C/T

T: ↑

*↓ in non-ApoE ε4 carrier in both Caucasians and Han Chinese.

Case–control

[19],[148]

 

IL-4 [149]

\

\

\

\

-1098 T/G (rs2243248)

G: Possibly ↓

*↑ in Han Chinese

Case–control

[150]

T: Possibly ↓

*↑ in Caucasians

[151]

-590 C/T (rs2243250)

C: ↓

*↑ in Han Chinese and Caucasians

[150], [151]

IL-6 family

IL-6 [152, 153]

=

\

↑or =

= or ↑

-174 G/C (rs1800795)

C: ↓

*↓ in Asians, No* in Caucasians.

Meta-analysis

[10].

*↓ in Italians.

Case–control

[25]

-572 C/G (rs1800796)

C: ?

*↑ in ApoE ε4 carriers.

Case–control

[16]

IL-11 [154]

=

\

= or ↑

\

\

\

\

\

 

IL-10 [155, 156]

=

= or ↑

=

-1082 A/G (rs1800896)

A: ?

*↑ in Caucasians, No* in Asians.

Meta- analysis

[11]

G: ↑

↓ in Caucasians

Meta- analysis

[22]

-819 T/C (rs1800871)

?

no *

-592 A/C (rs1800872)

-1082G/-819C/-592C

?

IL-12 family [157]

IL-12A

=

\

=

=

rs2243115 T/G

G: ↓

*↓ in LOAD in ApoE ε4 carrier of Northern Han Chinese

Case–control

[17]

rs568408 G/A

A: ↓

*↓ in LOAD of Northern Han Chinese

IL-12B

=

\

=

=

rs3212227 A/C

C: ↓

*↓ in LOAD of Northern Han Chinese

IL-23

\

\

\

\

rs10889677 A/C (L-23R)

C: ↓

*↓ risk in Northern Han Chinese.

Case–control

[18]

rs1884444 T/G (IL-23R)

G: ↓

*↑ in ApoE ε4 carrier of Northern Han Chinese.

Case–control

 

IL-15 [158]

\

\

=

=[159]

\

\

\

\

\

 

IL-16 [160]

\

\

\

\

rs4072111 C/T

T: ?

*↓ in LOAD of Iranians.

Case–control

[161]

 

IL-17 [162]

\

\

\

\

\

\

\

\

\

 

TNF-α [163]

= or ↑

= or ↑ or ↓

= or ↑ or ↓

-308 G/A (rs1800629)

A: ↑

*↑ in East Asian

Meta-analysis

[12], [13]

*↓ in Northern European population.

No* in Italians

Case–control

[25]

 

TGF-β [164]

\

↑ or ↓ or =

↑ or ↓ or =

\

\

\

\

\

 

IFN-γ [165]

\

\

=

=

-874 T/A (rs62559044)

A: ↓

*↑ in fast progressing AD

Case–control

[27]

  1. Abbreviation: IL-1 ra IL-1 receptor antagonist, EOAD early-onset Alzheimer’s disease, LOAD late-onset Alzheimer’s disease
  2. aEach cytokine or cytokine family was supplemented with a latest review for detailed information of physiological parameters
  3. b↑: up-regulated, ↓: down-regulated, =: no change, \: no data. Unless otherwise noted, all the data of cytokine levels is from Brosseron et al. 2014 [8]
  4. c↑: enhance the cytokine expression, ↓: attenuate the cytokine expression, ?: unknown yet
  5. d*: significant, ↑: higher risk of AD onset, ↓: lower risk of AD onset